Transforming growth factor-β: Multiple effects on cell differentiation and extracellular matrices

Developmental Biology

Volumn 130, Issue 2, 1988, Pages 411-422

  Rizzino, Angie ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANIMAL CELL; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; FORECASTING; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTORS;

EID: 0024263315     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/0012-1606(88)90337-5     Document Type: Review

References (147)

1. Antagonistic interactions of transforming growth factors in the regulation of granulosa cell differentiation
2. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis
3. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta
4. Increased secretion of type β transforming growth factor accompanies viral transformation of cells
5. Expression and secretion of type β transforming growth factor by activated human macrophages
6. Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts
7. Transforming growth factor-β in human platelets
8. Transforming growth factor β inhibits Leydig cell functions
9. A nonmitogenic pituitary function of fibroblast growth factor: Regulation of thyrotropin and prolactin secretion
10. Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans
11. The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts
12. Dynamic reciprocity: How do extracellular matrix and hormones direct gene expression?
13. How does the extracellular matrix direct gene expression?
14. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells
15. Role of the cytoskeleton in laminin induced mammary gene expression
16. Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvariae
17. Transforming growth factor (TGFβ) stimulates fibronectin and laminin synthesis in human colon carcinoma cells
18. TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events
19. Cellular distribution of type I and type II receptors for transforming growth factor-β
20. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
21. Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells
22. Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-β on the production of secreted proteins by murine 3T3 cells and human fibroblasts
23. Bovine adrenocortical cells exhibit high affinity transforming growth factor-β receptors which are regulated by adrenocorticotropin
24. The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse
25. The organization of mesodermal pattern in Xenopus laevis: Experiments using a Xenopus mesoderm-inducing factor
26. Mechanism of insulin action on membrane protein recycling: A selective decrease in the phosphorylation state of insulin-like growth factor II receptors in the cell surface membrane
27. The 140-kDa fibronectin receptor complex is required for mesodermal cell adhesion during gastrulation in the amphibian Pleurodeles waltlii
28. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family
29. Growth factors from murine sarcoma virus-transformed cells
30. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
31. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
32. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
33. Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells
34. Type β transforming growth factor is a potent modulator of differentiated adrenocortical cell functions
35. Type β transforming growth factor affects adrenocortical cell-differentiated functions
36. Transforming growth factor β regulates the inhibitory actions of epidermal growth factor during granulosa cell differentiation
37. Transforming growth factor-β stimulates meiotic maturation of the rat oocyte
38. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts
39. Transforming growth factor-β: A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by buffalo rat liver cells
40. Role of cell shape in growth control
41. Transforming growth factor-beta inhibits endothelial cell proliferation
42. Mesoderm-inducing factors: A small class of molecules
43. Cellular shape is determined by the extracellular matrix and is responsible for the control of cellular growth and function
44. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class
45. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA
46. Developmentally regulated expression of insulin-like growth factors by differentiated murine teratocarcinomas and extraembryonic mesoderm
47. Role of transforming growth factor-β in the development of the mouse embryo
48. Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types
49. Density-dependent regulation of growth of BSC-1 cells in cell culture: Growth inhibitors formed by the cells
50. Differential effects of transforming growth factor type β on the growth and function of adrenocortical cells in vitro
51. 2-macroglobulin complex is a latent form of transforming growth factor β
52. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β
53. Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts
54. Cell adhesion protein receptors as targets for transforming growth factor-β action
55. Human transforming growth factor type β2: Production by a prostatic adenocarcinoma cell line, purification, and initial characterization
56. Complementary deoxynucleic acid cloning of a novel transforming growth factor-β messenger ribonucleic acid from chick embryo chondrocytes
57. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes
58. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
59. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β: Divergent responses in lung fibroblasts and carcinoma cells
60. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells
61. Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early Xenopus embryo
62. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
63. Transforming growth factor-β regulates the expression of luteinizing hormone receptors in ovarian granulosa cells
64. Cells transformed by Rous sarcoma virus release transforming growth factors
65. Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor β inhibits proliferation and stimulates differentiation
66. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor
67. Normal embryo fibroblasts release transforming growth factors in a latent form
68. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
69. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: A proposed model for indirect mitogenesis involving autocrine activity
70. The antiproliferative effect of type β transforming growth factor occurs at a level distal from receptors for growth-activating factors
71. Transforming growth factor-β inhibits Leydig cell steroidogenesis in primary culture
72. Regulation of normal and variant mouse myoblast proliferation and differentiation by specific growth factors
73. Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor
74. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts
75. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium
76. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix
77. Subunit structure of a high-affinity receptor for type β transforming growth factor Evidence for a disulphide-linked glycosylated receptor complex
78. The TGF-β family of growth and differentiation factors
79. Type β transforming growth factor is an inhibitor of myogenic differentiation
80. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells
81. Casein gene expression in mouse mammary epithelial cell lines: Dependence upon extracellular matrix and cell type
82. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation
83. Latent high molecular weight complex of transforming growth factor β1
84. Transforming growth factor β modulates epidermal growth factor-induced phosphoinositide metabolism and intracellular calcium levels
85. Inhibitory action of transforming growth factor β on endothelial cells
86. Expression of TGF-beta gene in adult T cell leukemia
87. Type-β transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells
88. Type β transforming growth factor (TGFβ) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells
89. Latent transforming growth factor-β in serum
90. Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells
91. Regulation of myogenic differentiation by type β transforming growth factor
92. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture
93. A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-β family
94. Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability
95. Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones
96. 6 myoblasts
97. Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts
98. Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells
99. Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor
100. Behavior of transforming growth factors in serum-free media: An improved assay for transforming growth factors
101. Soft agar growth assays for transforming growth factors and mitogenic peptides
102. Appearance of high affinity receptors for type β transforming growth factor during differentiation of murine embryonal carcinoma cells
103. Production of PDGF-like growth factors by embryonal carcinoma cells and binding of PDGF to their endoderm-like differentiated cells
104. Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines
105. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-β
106. Regulatory effects of cell density on the binding of transforming growth factor-β, epidermal growth factor, platelet-derived growth factor and fibroblast growth factor
107. Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells
108. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues
109. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
110. Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
111. Mesoderm induction in amphibians: The role of TGF-β2-like factors
112. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro
113. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β
114. Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones
115. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells
116. Membrane binding characteristics of two forms of transforming growth factor-β
117. Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-β
118. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone
119. Reversible inhibition of mammary gland growth by transforming growth factor-β
120. Use of agarose culture to measure the effect of transforming growth factor β and epidermal growth factor on rabbit articular chondrocytes
121. Mesoderm induction in early Xenopus embryos by heparinbinding growth factors
122. A mesoderm-inducing factor is produced by a Xenopus cell line
123. Transforming growth factor type β is a specific inhibitor of 3T3 T mesenchymal stem cell differentiation
124. Decapentaplegic: A gene complex affecting morphogenesis in Drosophila melanogaster
125. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes
126. Transforming growth factor-β: Biological function and chemical structure
127. Some recent advances in the chemistry and biology of transforming growth factor-beta
128. Autocrine secretion and malignant transformation of cells
129. Gastrulation movements provide an early marker of mesoderm induction in Xenopus laevis
130. TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression
131. Identification of another member of the transforming growth factor type β gene family
132. Specific induction of secreted proteins by transforming growth factor-β and 12-O-tetradecanoyl-phorbol-13-acetate
133. Fibroblast growth factors
134. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1
135. The neurite-promoting effect of fibroblast growth factor on PC12 cells
136. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells
137. Phenotypic transformation of normal rat kidney cells in a growth-factor defined medium: Induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor
138. Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts
139. Transforming growth factor type β induces monocyte chemotaxis and growth factor production
140. Latent transforming growth factor-beta from human platelets: A high molecular weight complex containing precursor sequences
141. A maternal mRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-β
142. r = 35,000 surfactant-associated protein in fetal lung
143. Extracellular matrix promotes mammary epithelial growth and differentiation in vitro
144. Modulation of epidermal growth factor receptors on 3T3 cells by platelet-derived growth factor
145. Inhibin and beta transforming growth factor (TGFβ) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells
146. Regulation of casein RNA stability by basement membrane